Aptevo Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "4-1BB AND OX40 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS, ANTIBODIES AGAINST 4-1BB, ANTIBODIES AGAINST OX40 (FOR THE TREATMENT OF CANCER)".
Benzinga Newsdesk 3 months ago
BiotechGeneralNews
https://patentcenter.uspto.gov/applications/17634631/ifw/docshttps://x.com/PatentGrants/status/2074946217625493850